Zhejiang Jingxin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Jingxin Pharmaceutical") announces that the Board of Directors and all members guarantee the authenticity, accuracy, and completeness of the information disclosed, with no false records, misleading statements, or significant omissions.
The Company approved the implementation of the fourth employee stock ownership plan at the 18th meeting of the 8th Board of Directors held on September 29, 2025, and at the second extraordinary general meeting of shareholders held on October 20, 2025. For detailed information, please refer to the relevant announcements disclosed on the Giant Tide Information Network (www.cninfo.com.cn).
According to the "Guiding Opinions on the Pilot Implementation of Employee Stock Ownership Plans by Listed Companies" and the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standardized Operations of Main Board Listed Companies," the progress of the fourth employee stock ownership plan (hereinafter referred to as "this employee stock ownership plan") is announced as follows:
- Source and Quantity of Shares for This Employee Stock Ownership Plan
The shares for this employee stock ownership plan are sourced from the A-share common stock repurchased by the Company through a dedicated securities account. The Company approved the share repurchase plan at the 12th meeting of the 8th Board of Directors held on January 8, 2025. The Company agreed to use its own funds to repurchase shares through centralized bidding, and the repurchased shares will be used for equity incentives or employee stock ownership plans. On January 8, 2026, the Company disclosed the completion of the share repurchase, having repurchased a total of 47,271,295 shares, accounting for 5.49% of the current total share capital, with the highest transaction price at 14.41 yuan/share and the lowest at 11.86 yuan/share, totaling 608.722 million yuan (excluding transaction fees). All repurchased shares are held in the dedicated repurchase securities account. The number of shares transferred through non-transaction transfer for the first grant of this employee stock ownership plan is 7,123,400 shares, accounting for 0.83% of the current total share capital, all sourced from the aforementioned repurchased shares, with no difference in actual use compared to the intended use in the repurchase plan. After this non-transaction transfer is completed, the remaining repurchased shares in the dedicated repurchase securities account are 40,147,895 shares.